Bitrobius Genetics logo

Bitrobius Genetics

Developing the Gentrafix platform technology to revolutionise gene therapy.

6 employees · est. 2020 · Macclesfield, United Kingdom

VS
Dyno Therapeutics logo

Dyno Therapeutics

We build AI-powered gene therapies.

95 employees · est. 2018 · Watertown, United States

Dyno Therapeutics is the older company (2020 vs 2018); Dyno Therapeutics is the larger of the two.

Side-by-Side Comparison

Bitrobius Genetics Dyno Therapeutics
Founded
2020 2018 older
Headquarters
Macclesfield, United Kingdom Watertown, United States
Employees
6 95 larger
Industry
Biotechnology, Health Care Biotechnology, Pharmaceutical
Funding Stage
Series A Series A
Total Funding
Not tracked yet $109.00M
Funding Rounds
1 3
Services
Not tracked yet Development of high-performance genetic technologies, AI-driven solutions for genetic advancements, Collaborative partnerships in genetic research
Target Customers
Not tracked yet Patients requiring genetic intervention, Healthcare providers, Pharmaceutical companies seeking genetic solutions
Taxonomy
Gene Therapy, DNA Transfer Technology, Genetic Diseases, Cancer Therapy, Biomedical Engineering AI-powered Gene Therapy, High-Performance Genetic Technologies, Machine Learning In Gene Therapy, Gene Vector Design, Adeno-Associated Virus (AAV) Engineering, Cell-Targeting Capsid Proteins, Synthetic Biology, Next-Generation Sequencing (NGS), In Vivo Experimentation, Data Science In Genomics, Genome Editing, Protein Engineering, Biotechnology Innovations, AI In Healthcare, Therapeutic Development
Website
bitrobius.com dynotx.com
Bitrobius Genetics logo

About Bitrobius Genetics

Bitrobius Genetics is a biotechnology startup, founded in 2020, with a passionate vision of utilizing the Gentrafix™ platform to revolutionize gene therapy. The company's slogan, "Developing the Gentrafix platform technology to revolutionise gene therapy," underscores its commitment to addressing a...

Dyno Therapeutics logo

About Dyno Therapeutics

Dyno Therapeutics is an innovative player in the biotechnology and pharmaceutical industries, pioneering the development of AI-powered gene therapies. Founded in 2018, the company is committed to building high-performance genetic technologies designed to transform patient lives. Headquartered in the...

We will tell you when either one moves

BounceWatch watches Bitrobius Genetics and Dyno Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Bitrobius Genetics and Dyno Therapeutics — by email.

Frequently Asked Questions

Bitrobius Genetics — Developing the Gentrafix platform technology to revolutionise gene therapy.. Dyno Therapeutics — We build AI-powered gene therapies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Bitrobius Genetics has raised undisclosed funding while Dyno Therapeutics has raised $109.00M.
Bitrobius Genetics and Dyno Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Bitrobius Genetics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Bitrobius Genetics on 20 Dec 2024, and Dyno Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy